Studies have shown that abnormal expression of E2F7 in a variety of malignant tumors may be involved in the occurrence and development of tumors, such as skin squamous cell carcinoma, endometrial carcinoma, etc. [53, 54]. This evidence concerns the gene E2F7 and cancer.